Human Immunodeficiency Virus Status Does Not Independently Predict 2-Year Complications Following Total Knee Arthroplasty

Abstract

With improved treatment for human immunodeficiency virus (HIV), the demand for total knee arthroplasty (TKA) in this population has increased. Studying the relationship between HIV and postoperative complications following TKA will allow orthopaedic surgeons to accurately assess their patients' surgical risk and provide appropriate counseling. This study aims to understand how HIV impacts surgical and medical complications following TKA for osteoarthritis (OA). Patients identified in a national insurance database who underwent TKA for OA from 2010 to 2019 were divided into three cohorts: no HIV, asymptomatic HIV, and acquired immunodeficiency syndrome (AIDS). Univariate and multivariable regression analyses were performed to determine 90-day postoperative complications as well as 2-year surgical complications (revision surgery, prosthetic joint infection, aseptic loosening, and manipulation under anesthesia). A total of 855,373 patients were included, of whom 1,338 had asymptomatic HIV and 268 had AIDS. After multivariable regression analysis, patients with HIV had no difference in 2-year surgical complications relative to the control cohort. Within 90 days postoperatively, patients with asymptomatic HIV had increased odds of arrhythmia without atrial fibrillation and lower odds of anemia. Patients with AIDS had increased odds of anemia and renal failure. Patients with HIV and AIDS are at an increased risk for developing 90-day medical complications and 2-year surgical complications. However, after accounting for their comorbidities, the risk of 90-day complications was only mildly increased and the risk of 2-year surgical complications approximated the control cohort. Surgeons should pay particular attention to these patients' overall comorbidities, which appear to be more closely associated with postoperative risks than HIV status alone. Level of evidence: III.

Keywords

total knee arthroplasty - human immunodeficiency virus - acquired immunodeficiency syndrome - postoperative complications - medical complications - surgical complications

Publication History

Received: 04 October 2021

Accepted: 19 June 2022

Article published online:
09 August 2022

• References

• 1 Hootman JM, Helmick CG. Projections of US prevalence of arthritis and associated activity limitations. Arthritis Rheum 2006; 54 (01) 226-229
• 2 Lawrence RC, Felson DT, Helmick CG. et al; National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008; 58 (01) 26-35
• 3 Takacs J, Carpenter MG, Garland SJ, Hunt MA. The role of neuromuscular changes in aging and knee osteoarthritis on dynamic postural control. Aging Dis 2013; 4 (02) 84-99
• 4 Parvizi J, Sullivan TA, Pagnano MW, Trousdale RT, Bolander ME. Total joint arthroplasty in human immunodeficiency virus-positive patients: an alarming rate of early failure. J Arthroplasty 2003; 18 (03) 259-264
• 5 Chalmers BP, Abdel MP, Taunton MJ, Trousdale RT, Pagnano MW. Mid-term results of total hip and total knee arthroplasty in patients with human immunodeficiency virus. Orthopedics 2017; 40 (04) e699-e702
• 6 Moore RD. Epidemiology of HIV infection in the United States: implications for linkage to care. Clin Infect Dis 2011; 52 (Suppl. 02) S208-S213
• 7 Falakassa J, Diaz A, Schneiderbauer M. Outcomes of total joint arthroplasty in HIV patients. Iowa Orthop J 2014; 34: 102-106
• 8 Roof MA, Anoushiravani AA, Chen KK. et al. Outcomes of total knee arthroplasty in human immunodeficiency virus-positive patients. J Knee Surg 2020; 33 (08) 754-761
• 9 O'Neill SC, Queally JM, Hickey A, Mulhall KJ. Outcome of total hip and knee arthroplasty in HIV-infected patients: a systematic review. Orthop Rev (Pavia) 2019; 11 (01) 8020
• 10 Lin CA, Kuo AC, Takemoto S. Comorbidities and perioperative complications in HIV-positive patients undergoing primary total hip and knee arthroplasty. J Bone Joint Surg Am 2013; 95 (11) 1028-1036
• 11 Issa K, Pierce TP, Harwin SF, Scillia AJ, Festa A, Mont MA. No decrease in knee survivorship or outcomes scores for patients with HIV infection who undergo TKA. Clin Orthop Relat Res 2017; 475 (02) 465-471
• 12 Rodriguez-Merchan EC, Wiedel JD. Total knee arthroplasty in HIV-positive haemophilic patients. Haemophilia 2002; 8 (03) 387-392
• 13 Rodriguez-Merchan EC. Total knee arthroplasty in patients with haemophilia who are HIV-positive. J Bone Joint Surg Br 2002; 84 (02) 170-172
• 14 Trieb K, Panotopoulos J, Wanivenhaus A. Risk of infection after total knee arthroplasty in HIV-positive hemophilic patients. J Bone Joint Surg Am 2003; 85 (05) 969-970 , author reply 969–970
• 15 Cms.gov.. 2018 ICD-10-CM Official Guidelines for Coding and Reporting FY 2019. Accessed July 27, 2021 at: https://www.cms.gov/Medicare/Coding/ICD10/Downloads/2019-ICD10-Coding-Guidelines-.pdf
• 16 Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998; 36 (01) 8-27
• 17 Burgoyne RW, Tan DH. Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act. J Antimicrob Chemother 2008; 61 (03) 469-473
• 18 Enayatollahi MA, Murphy D, Maltenfort MG, Parvizi J. Human immunodeficiency virus and total joint arthroplasty: the risk for infection is reduced. J Arthroplasty 2016; 31 (10) 2146-2151
• 19 Olson JJ, Schwab PE, Jackson J, Lange JK, Bedair HS, Abdeen A. HIV-positive patients are at increased risk of venous thromboembolism after total joint replacement. J Am Acad Orthop Surg 2021; 29 (11) 479-485
• 20 Boylan MR, Basu N, Naziri Q, Issa K, Maheshwari AV, Mont MA. Does HIV infection increase the risk of short-term adverse outcomes following total knee arthroplasty?. J Arthroplasty 2015; 30 (09) 1629-1632
• 21 Capogna BM, Lovy A, Blum Y, Kim SJ, Felsen UR, Geller DS. Infection rate following total joint arthroplasty in the HIV population. J Arthroplasty 2013; 28 (08) 1254-1258